The Prioritising Recruitment in Randomised Trials study (PRioRiTy) identified research questions which focus on how to improve the process of recruiting people to randomised trials. The study was a priority setting partnership (PSP) based on the methods of the James Lind Alliance (JLA). The JLA (UK) brings patients, carers and healthcare professionals together in Priority Setting Partnerships. These partnerships identify and prioritise unanswered questions about healthcare that the public, carers and professionals jointly agree are the most important. The aim of this is to help ensure that those who fund health research are aware of what future research will really matter in everyday use. The PRioRiTy PSP was focussed on methodological uncertainties rather than on treatment uncertainties and therefore a modified JLA approach was developed and used.
This question is about how might trials co-exist, routinely, alongside routine clinical care. Research is often viewed by clinicians as an extra burden or an added strain on already limited resources, rather than something that (should) co-exist alongside routine care.
Best approaches”’ might include, for example; website, leaflets,
“Barriers and enablers” might include, for example; time, experience, workload and training.
Key motivators might include, for example; altruism, aspects of care, benefit. Certain motivators for some people could be de-motivators for others; researchers might need to consider this if designing a study to addresses this question.
Under-represented or vulnerable groups might include, for example, children or people with rare diseases. This uncertainty is not about doing trials in these populations, exclusively, but about including participants from these groups where they are eligible as part of a ‘wider’ target population (e.g. the general public).
What level/ grade and what type of person (doctor, nurse, research assistant) is needed to gain informed consent?”
Technology might include, for example, mobile applications, websites and e-health.